Yijia Li Selected Research

Yijia Li Research Topics

Disease

18	COVID-19 01/2024 - 10/2020
10	Viremia 02/2024 - 01/2021
7	Neoplasms (Cancer) 03/2024 - 01/2021
6	Infections 04/2024 - 07/2015
4	Coinfection 01/2017 - 09/2012
3	Inflammation (Inflammations) 03/2023 - 10/2020
2	HIV Infections (HIV Infection) 02/2024 - 01/2017
2	Acquired Immunodeficiency Syndrome (AIDS) 02/2024 - 01/2023
2	Hematologic Neoplasms (Hematological Malignancy) 01/2024 - 08/2023
2	Fibrosis (Cirrhosis) 01/2023 - 02/2016
2	Hypoxia (Hypoxemia) 01/2023 - 10/2021
2	Hepatitis B 01/2017 - 01/2016
2	Liver Diseases (Liver Disease) 02/2016 - 01/2016
1	Colorectal Neoplasms (Colorectal Cancer) 03/2024
1	Adenocarcinoma of Lung 01/2024
1	Hyperandrogenism 12/2023
1	Placental Insufficiency 12/2023
1	Persistent Infection 11/2023
1	Hypothyroidism 10/2023
1	Hypertrophy 01/2023
1	Hepatocellular Carcinoma (Hepatoma) 01/2022
1	Hyperthermia 01/2022
1	Triple Negative Breast Neoplasms 10/2021
1	Critical Illness (Critically Ill) 10/2021
1	Acute Lung Injury 01/2021
1	Insulin Resistance 12/2020
1	Hyperlipidemias (Hyperlipidemia) 12/2020
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 12/2020
1	Body Weight (Weight, Body) 12/2020
1	Parasitemia 10/2020
1	Necrosis 11/2019
1	Foodborne Diseases 11/2019
1	Nephrosis 11/2019

Drug/Important Bio-Agent (IBA)

7	Antiviral Agents (Antivirals)IBA 01/2024 - 12/2021
5	RNA (Ribonucleic Acid)IBA 01/2023 - 10/2020
4	DNA (Deoxyribonucleic Acid)IBA 02/2024 - 05/2016
4	Proteins (Proteins, Gene)FDA Link 12/2023 - 11/2019
3	nirmatrelvir and ritonavir drug combinationIBA 11/2023 - 06/2023
3	bamlanivimabIBA 01/2023 - 12/2021
3	Nucleic AcidsIBA 12/2021 - 01/2021
2	AntigensIBA 03/2024 - 12/2021
2	mRNA VaccinesIBA 03/2024 - 11/2023
2	Viral RNAIBA 01/2024 - 08/2023
2	Insulin (Novolin)FDA Link 12/2023 - 12/2020
2	Complement System Proteins (Complement)IBA 11/2023 - 01/2022
2	CytokinesIBA 01/2023 - 01/2021
2	Monoclonal AntibodiesIBA 01/2022 - 12/2021
2	FurinIBA 02/2021 - 01/2021
2	Glucose (Dextrose)FDA LinkGeneric 12/2020 - 11/2019
2	Lamivudine (Epivir)FDA Link 05/2016 - 09/2012
1	Messenger RNA (mRNA)IBA 03/2024
1	Cancer VaccinesIBA 03/2024
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 03/2024
1	Immunologic Factors (Immunomodulators)IBA 02/2024
1	Anaplastic Lymphoma KinaseIBA 01/2024
1	alectinibIBA 01/2024
1	Immunoglobulin G (IgG)IBA 11/2023
1	AntibodiesIBA 11/2023
1	nirmatrelvirIBA 11/2023
1	Ritonavir (Norvir)FDA Link 11/2023
1	MetalsIBA 10/2023
1	salicylhydroxamic acid (SHAM)IBA 10/2023
1	GS-621763IBA 06/2023
1	Dopamine (Intropin)FDA LinkGeneric 03/2023
1	poly(lactide) (polylactic acid)IBA 03/2023
1	Histone Deacetylases (Histone Deacetylase)IBA 01/2023
1	HLA Antigens (Human Leukocyte Antigens)IBA 01/2023
1	Interleukin-7 (Interleukin 7)IBA 01/2023
1	Vorinostat FDA Link 01/2023
1	Oxygen (Dioxygen)IBA 01/2023
1	Atrial Natriuretic Factor (ANF)IBA 01/2023
1	N-(2-cyanoethylene)urea (BA 1)IBA 01/2022
1	VaccinesIBA 12/2021
1	laponiteIBA 10/2021
1	Vasopressins (Vasopressin)IBA 10/2021
1	CD3 ComplexIBA 10/2021
1	InterleukinsIBA 01/2021
1	PowdersIBA 01/2021
1	AcidsIBA 12/2020
1	LipidsIBA 12/2020
1	loquat extractIBA 12/2020
1	Glutathione (Reduced Glutathione)IBA 12/2020
1	Lipid PeroxidesIBA 12/2020
1	TriterpenesIBA 12/2020
1	Interleukin-6 (Interleukin 6)IBA 10/2020
1	C-Reactive ProteinIBA 10/2020
1	Azithromycin (Zithromax)FDA LinkGeneric 10/2020
1	Clindamycin (Cleocin)FDA LinkGeneric 10/2020
1	Atovaquone (Mepron)FDA Link 10/2020
1	Biomarkers (Surrogate Marker)IBA 11/2019

Therapy/Procedure

14	Therapeutics 01/2024 - 09/2012
5	Art Therapy 02/2024 - 01/2016
3	Artificial Respiration (Mechanical Ventilation) 02/2021 - 01/2021
2	Highly Active Antiretroviral Therapy (HAART) 03/2023 - 02/2016
2	Drug Therapy (Chemotherapy) 01/2022 - 10/2021
1	Immunotherapy 03/2024
1	Intramuscular Injections 03/2024
1	Aftercare (After-Treatment) 02/2024
1	Secondary Prevention 11/2023
1	Blood Component Removal (Apheresis) 10/2020